{
  "retracted": false,
  "timestamp": 1545868800000,
  "updates": [
    {
      "timestamp": 1586880096220,
      "identifier": {
        "doi": "10.1182/blood-2018-11-884247"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2017-05-785659"
  },
  "publisher": "American Society of Hematology",
  "title": "Ciurea SO, Schafer JR, Bassett R, et al. Phase 1 clinical trial using mbIL21 ex vivoâ€“expanded donor-derived NK cells after haploidentical transplantation. Blood. 2017;130(16):1857-1868."
}
